Invion Limited (IVIXF)
IVIXF Stock Price Chart
Explore Invion Limited interactive price chart. Choose custom timeframes to analyze IVIXF price movements and trends.
IVIXF Company Profile
Discover essential business fundamentals and corporate details for Invion Limited (IVIXF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
17 May 2013
Employees
—
Website
https://www.inviongroup.comCEO
Thian Chew
Description
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.
IVIXF Financial Timeline
Browse a chronological timeline of Invion Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Feb 2026
Earnings released on 29 Aug 2025
Earnings released on 4 Mar 2025
Earnings released on 26 Feb 2025
EPS came in at -$0.02 .
Stock split effective on 20 Nov 2024
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Oct 2024
Earnings released on 30 Aug 2024
EPS came in at -$0.05 , while revenue for the quarter reached $977.12K .
Earnings released on 30 Apr 2024
Earnings released on 27 Feb 2024
EPS came in at -$0.01 , while revenue for the quarter reached $1.52M .
Earnings released on 30 Sept 2023
EPS came in at -$0.00 , while revenue for the quarter reached $716.26K .
Earnings released on 29 Jun 2023
EPS came in at -$0.01 , while revenue for the quarter reached $1.44M .
Earnings released on 31 Mar 2023
EPS came in at -$0.00 , while revenue for the quarter reached $721.72K .
Earnings released on 31 Dec 2022
EPS came in at -$0.00 , while revenue for the quarter reached $662.27K .
Earnings released on 30 Sept 2022
EPS came in at -$0.00 , while revenue for the quarter reached $622.20K .
Earnings released on 29 Jun 2022
EPS came in at -$0.01 , while revenue for the quarter reached $1.38M .
Earnings released on 30 Dec 2021
EPS came in at -$0.01 , while revenue for the quarter reached $942.08K .
Earnings released on 29 Jun 2021
EPS came in at -$0.01 , while revenue for the quarter reached $815.09K .
Earnings released on 30 Dec 2020
EPS came in at -$0.01 , while revenue for the quarter reached $960.18K .
IVIXF Stock Performance
Access detailed IVIXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.